Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/08/1987 | US4711847 Preparation of secretin |
12/08/1987 | US4711782 Prolonged release microcapsules and their production |
12/08/1987 | CA1230069A1 Modified protease inhibitors, process for their preparation, and pharmaceutical compositions prepared therefrom |
12/08/1987 | CA1230053A1 Gamma interferon - lymphotoxin synergism |
12/07/1987 | EP0191771A4 Automatic injector assembly. |
12/03/1987 | WO1987007305A1 A dna sequence encoding the ros oncogene, polypeptides encoded therefrom, and diagnostic and other methods based thereon |
12/03/1987 | WO1987007303A1 New lymphokine for the suppression of platelet activation |
12/03/1987 | WO1987007297A1 Lipopolysaccharides of reduced toxicity and the production thereof |
12/03/1987 | WO1987007296A1 Expression of human t-cell lymphotropic virus (htlv-iii) reverse transcriptase and uses thereof |
12/03/1987 | WO1987007277A1 Fc receptor for immunoglobulin |
12/03/1987 | WO1987007276A1 Novel 5-fluorouridine compounds and process for their preparation |
12/03/1987 | WO1987007149A1 Pharmaceutical compositions |
12/03/1987 | WO1987007146A1 INHIBITOR OF C5a-MEDIATED CHEMOTAXIS |
12/03/1987 | WO1987007145A1 D-gl conjugate therapy |
12/03/1987 | WO1987007144A1 Novel procoagulant proteins |
12/03/1987 | DE3718476A1 Verfahren zur herstellung von konjugaten von metallproteinen und neuen derivaten hiervon A process for the preparation of conjugates of proteins and new metal derivatives thereof |
12/03/1987 | DE3716437A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
12/02/1987 | EP0247998A2 Process for the inactivation of propagating filtrable pathogenic microbes |
12/02/1987 | EP0247906A2 DNA coding for anti-tumour polypeptides, the polypeptides and anti-tumour agents comprising said polypeptides |
12/02/1987 | EP0247873A2 Bacteriocins and compositions thereof in anti-viral treatment |
12/02/1987 | EP0247860A2 Tumor necrosis factor formulation and its preparation |
12/02/1987 | EP0247843A2 Human protein S, A plasma protein regulator of hemostasis |
12/02/1987 | EP0247674A1 Plasminogen activator and thrombolytic composition |
12/02/1987 | EP0247613A2 Improved process for preparing lymphokine activated killer cells |
12/02/1987 | EP0247258A1 Process for concentrating and separating trypsin inhibitor and kallidinogenase in human urine |
12/02/1987 | EP0247033A1 Conformationally constrained oxytocin antagonists with prolonged biological activities |
12/02/1987 | CN86108955A Growth regulating factor for new cell |
12/01/1987 | US4710490 Solvent extraction of mammalian tissue |
12/01/1987 | US4710488 Synthetic blood; low oxygen affinity |
12/01/1987 | US4710469 Novel phosphotyrosyl protein phosphatase |
12/01/1987 | US4710463 Recombinant DNA molecules capable of expressing HBV core and surface antigens |
12/01/1987 | US4710457 Differentiating b- and t-lymphocytes by complexing, precipitation and electrophoresis |
12/01/1987 | US4710382 Periodic administration of hormone until bone mass increases |
12/01/1987 | US4710381 Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
12/01/1987 | US4710376 Topical therapeutic composition containing oxidation inhibitor system |
12/01/1987 | CA1229791A1 Drug composition containing fc fragments of human igg |
12/01/1987 | CA1229789A1 Polypeptides exhibiting skeletal growth factor activity |
11/26/1987 | DE3716794A1 New mixed salts of amino acid mono:fluoro:phosphate(s) with sodium chl |
11/25/1987 | EP0246975A1 Immuno-suppressive compounds, their preparation by cultivating streptomyces sp. (cbs 162.86) and pharmaceutical compositions containing them |
11/25/1987 | EP0246967A1 Platelet activation suppressive lymphokine, process for isolating and purifying it, and medicines containing it |
11/25/1987 | EP0246861A2 Use of compositions based on crotoxine, for the manufacture of a medicament for the treatment of carcinomas |
11/25/1987 | EP0246795A2 Synthetic natriuretic peptides |
11/25/1987 | EP0246753A2 Fibroblast growth factor antagonists |
11/25/1987 | EP0246747A1 Enteral diet product, agent and methods for its production |
11/25/1987 | EP0246653A2 Delayed/sustained release of macromolecules |
11/25/1987 | EP0246630A2 Antiviral peptides and means for treating herpes infections |
11/25/1987 | EP0246579A2 Method of producing immunoglobulin preparations for intravenous injection |
11/25/1987 | EP0246569A2 Superoxide dismutase derivatives, method of producing same and pharmaceutical composition |
11/25/1987 | EP0246540A2 Implant preparations for delivery of bioactive macromolecules |
11/25/1987 | EP0246439A1 Sterile plasma substitute |
11/25/1987 | EP0246381A1 Renin inhibitors and methods for using same |
11/25/1987 | EP0246322A1 Treatment of aids-type disease. |
11/25/1987 | EP0246307A1 Cys codon-modified dna. |
11/25/1987 | EP0246280A1 Treating increased intraocular pressure caused by steroids |
11/24/1987 | US4709015 Diagnosis and treatment of diseases |
11/24/1987 | US4709014 Human calcitonin; reaction of a c-terminal protein substrate with carboxypeptidase y in the presence of ammonia |
11/24/1987 | US4709013 Esterification, salt formation |
11/24/1987 | US4709012 Novel inhibitor peptides |
11/24/1987 | US4709010 Peptides useful for inhibition of renin |
11/24/1987 | US4708948 Substantially purified tumor growth inhibitory factor |
11/24/1987 | US4708930 Murine genus |
11/24/1987 | US4708862 Radioimmuno detection of human cancers using anti-tumor monoclonal antibody |
11/24/1987 | US4708718 Hyperthermic treatment of tumors |
11/24/1987 | CA1229588A1 Process for the preparation of insulin derivatives |
11/23/1987 | EP0211077A4 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same. |
11/19/1987 | WO1987006954A1 Production of m-csf |
11/19/1987 | WO1987006943A1 Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof |
11/19/1987 | WO1987006942A1 Substantially pure cytotoxicity triggering factor |
11/19/1987 | WO1987006941A1 Insulinotropic hormone |
11/19/1987 | WO1987006940A1 ASSAYS AND ANTIBODIES FOR N-myc PROTEINS |
11/19/1987 | WO1987006938A1 Atrial natriuretic peptide receptor protein and its encoding dna |
11/19/1987 | WO1987006836A1 Fibrinolytic composition |
11/19/1987 | WO1987006835A1 Combinations having synergistic growth hormone releasing activity and methods for use thereof |
11/19/1987 | WO1987006831A1 Composition and method for treating a thrombus and embolus |
11/19/1987 | WO1987006830A1 Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment |
11/19/1987 | WO1987005029A3 Peptides affecting blood pressure regulation |
11/19/1987 | EP0246149A2 Immunomodulating agents prepared by half-synthesis from a bacterial polysaccharide extracted from a mutant non-encapsulated strain of Klebsiella pneumoniae |
11/19/1987 | EP0246049A1 Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant |
11/19/1987 | EP0245993A2 Monoclonal antibodies against C5A and DES-ARG74-C5A, their production and use |
11/19/1987 | EP0245979A2 Novel phosphotyrosyl protein phosphatase |
11/19/1987 | EP0245956A2 Insulin activity messengers, their precursors and uses thereof |
11/19/1987 | EP0245875A2 Method of purifying factor VIII |
11/19/1987 | EP0245486A1 Method for treating genital and oral herpes |
11/19/1987 | EP0245432A1 Isoforms of soluble immune response suppressor |
11/19/1987 | EP0245361A1 Novel renin inhibiting polypeptide analogs containing s-aryl-d- or l- or dl-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties |
11/19/1987 | EP0245322A1 A composition for treating and preventing diarrhoea in humans and animals and a method of preparing same. |
11/19/1987 | DE3715662A1 Neue pharmazeutische anwendung New pharmaceutical application |
11/19/1987 | DE3616054A1 Homeopathic remedy for the treatment of rheumatic disorders |
11/18/1987 | CN87102538A Novel spergualin-related compounds and process for producing the same |
11/17/1987 | US4707541 Synthesis of hGRF (somatocrinin) in liquid phase and intermediate peptides |
11/17/1987 | US4707490 Amino acid esters of thiopropanoyl-3,4-dehydroproline |
11/17/1987 | US4707468 Polypeptide |
11/17/1987 | US4707443 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
11/17/1987 | US4707442 Hybrid cell line producing monoclonal antibody cytolytic to Trichomonas vaginalis |
11/11/1987 | EP0245218A2 A plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone |
11/11/1987 | EP0245136A1 Viral vector encoding a glycoprotein of the AIDS virus, vaccine and antibodies |
11/11/1987 | EP0245100A2 Purification of single-chain and double-chain tissue plasminogen activator |
11/11/1987 | EP0245051A1 Killer cell cytotoxic composition |
11/11/1987 | EP0245044A2 Method of regulating animal reproduction |
11/11/1987 | EP0244836A2 Tripeptide derivatives |